Intelligene Inc. (TPEX:7832)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Biotechnology Services and Research and Development Services	2.39M	4.68M	3.05M
Biotechnology Services and Research and Development Services Growth	-48.99%	53.49%	-
Total	2.39M	4.68M	3.05M
Total Growth	-48.99%	53.49%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Australia	2.39M	4.08M	3.05M
Australia Growth	-41.46%	33.75%	-
Taiwan	-	602.00K	-
Total	2.39M	4.68M	3.05M
Total Growth	-48.99%	53.49%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 17, 2026

Data Sources Report a data error